https://www.nlc.health https://www.nlc.health/investors https://www.nlc.health/corporates https://www.nlc.health/portfolio https://www.nlc.health/about https://www.nlc.health/funds https://www.nlc.health/ventures https://www.nlc.health/insights https://www.nlc.health/careers https://www.nlc.health/inventors https://www.nlc.health/team https://www.nlc.health/log-in https://www.nlc.health/sign-up https://www.nlc.health/reset-password https://www.nlc.health/update-password https://www.nlc.health/access-denied https://www.nlc.health/user-account https://www.nlc.health/career-detail https://www.nlc.health/archive-health-impact-fund-xtgh https://www.nlc.health/unlock-your-share-of-the-10-trillion-healthcare-revolution https://www.nlc.health/unlock-the-10-trillion-healthcare-revolution https://www.nlc.health/nlcs-health-impact-fund-teaser https://www.nlc.health/impact-report-2024 https://www.nlc.health/untitled-2 https://www.nlc.health/impact-report-2025 https://www.nlc.health/impact-report https://www.nlc.health/expertise/biotech https://www.nlc.health/expertise/cardiovascular https://www.nlc.health/expertise/general-healthtech https://www.nlc.health/insight/ai-healthtech-start-up-mindaffect-raises-eu1-1-million-to-transform-hearing-diagnostics https://www.nlc.health/insight/amotio-pre-seed https://www.nlc.health/insight/ansana-secures-a-eu850-000-investment https://www.nlc.health/insight/ansana-secures-a-eur-1-5-million-seed-round-to-bring-smart-sterilization-technology-to-market https://www.nlc.health/insight/check-out-our-latest-venture-charm https://www.nlc.health/insight/cuip-and-nlc-health-ventures-signed-a-mou-to-bring-cutting-edge-innovations-to-life https://www.nlc.health/insight/derisking-early-stage-investments-to-solve-global-healthcare-challenges https://www.nlc.health/insight/driving-return-and-impact-inside-the-nlc-health-impact-funds-vision-and-strategy https://www.nlc.health/insight/dutch-health-insurer-vgz-invests-eu6-million-in-nlc-health-ventures https://www.nlc.health/insight/from-invention-to-impact-inside-nlcs-venture-creation-and-selection-process https://www.nlc.health/insight/genorare-secures-pre-seed-funding-to-revolutionize-rare-disease-diagnosis-with-ai https://www.nlc.health/insight/haermonics-series-a-funding-offers-pure-promise-for-future-heart-surgery-patients https://www.nlc.health/insight/hemeo-raises-e675000-in-an-oversubscribed-seed-equity-round https://www.nlc.health/insight/innovation-and-collaboration-is-the-cure-to-solving-the-healthcare-crisis https://www.nlc.health/insight/introducing-aerion-bioscience-a-new-era-of-cancer-screening https://www.nlc.health/insight/introducing-aetherus-offering-rapid-relief-to-those-suffering-from-breathlessness https://www.nlc.health/insight/introducing-aido-building-the-future-platform-for-interventional-endoscopy https://www.nlc.health/insight/introducing-amotio-revolutionising-orthopaedic-revision-surgery-an-innovative-approach-to-major-joint-implant-revisions https://www.nlc.health/insight/introducing-ansana-a-new-sterilization-technology-for-the-healthcare-pharmaceutical-industry https://www.nlc.health/insight/introducing-asclepius-revolutionising-pre-and-post-operative-surgical-assessment-by-unleashing-and-unlocking-the-power-of-data https://www.nlc.health/insight/introducing-carebed-a-mobile-friendly-solution-for-the-elderly https://www.nlc.health/insight/introducing-crainio-revolutionising-the-measurement-of-intracranial-pressure https://www.nlc.health/insight/introducing-diaphone-therapeutics-developing-small-molecule-antagonists https://www.nlc.health/insight/introducing-heat2move-a-non-medical-and-non-invasive-pain-relieving-technology https://www.nlc.health/insight/introducing-liftya-stability-with-motion https://www.nlc.health/insight/introducing-occlunova-an-implantable-device-for-chronic-atrial-fibrillation-af https://www.nlc.health/insight/introducing-provasctec-a-cell-therapy-for-patients-with-critical-limb-ischemia https://www.nlc.health/insight/introducing-startric-transcatheter-tricuspid-heart-valve-repair https://www.nlc.health/insight/introducing-theragenix-gene-based-tissue-regeneration https://www.nlc.health/insight/ipd-secures-funding-of-eu2-1m-to-initiate-its-first-in-human-trials-for-prosthetic-joint-infections https://www.nlc.health/insight/meet https://www.nlc.health/insight/neurodys-therapeutics-secures-pre-seed-funding-to-advance-small-molecule-therapies-for-neurodegenerative-diseases https://www.nlc.health/insight/nina-rijnders-impact-investing-for-philanthropic-fund-in-dutch https://www.nlc.health/insight/nlc-announces-40-new-investments-in-high-impact-healthtech-ventures https://www.nlc.health/insight/nlc-completes-first-close-of-eu100m-health-impact-fund https://www.nlc.health/insight/nlc-health-ventures-and-hmg-are-announcing-partnership-to-accelerate-global-health-tech-innovations https://www.nlc.health/insight/nlc-health-ventures-introduces-new-venture-transforming-cardiovascular-care https://www.nlc.health/insight/nlc-health-ventures-launches-new-early-stage-drug-delivery-company https://www.nlc.health/insight/nlc-health-ventures-launches-new-venture-revolutionizing-rheumatoid-arthritis-care https://www.nlc.health/insight/nlc-hmg-launch-the-global-open-challenge https://www.nlc.health/insight/nlc-venture-altach-secures-eu1-2-million-investment-to-transform-treatments-for-cartilage-injuries https://www.nlc.health/insight/nlc-was-named-the-number-1-most-active-early-stage-investor-in-healthcare-in-europe-by-financial-times-sifted https://www.nlc.health/insight/nlc-was-named-the-number-1-most-active-early-stage-investor-in-healthcare-in-europe-by-financial-times-sifted-b8bc2 https://www.nlc.health/insight/ntroducing-our-venture-nilocas https://www.nlc.health/insight/porous-wins-innovation-award https://www.nlc.health/insight/rob-ten-hoedt-joins-supervisory-board https://www.nlc.health/insight/serda-therapeutics-announces-completion-of-first-phase-1-clinical-study-of-sn514 https://www.nlc.health/insight/the-future-of-healthcare-a-conversation-with-dr-fenna-heyning-on-reinventing-hospitals-for-the-digital-age https://www.nlc.health/insight/the-power-of-additionality-why-impact-investing-should-focus-on-building-companies-that-otherwise-wouldnt-exist https://www.nlc.health/portfolio/aerion-bioscience https://www.nlc.health/portfolio/aetherus https://www.nlc.health/portfolio/aido https://www.nlc.health/portfolio/allergios https://www.nlc.health/portfolio/altach https://www.nlc.health/portfolio/amotio https://www.nlc.health/portfolio/angiogenesis-analytics https://www.nlc.health/portfolio/ansana https://www.nlc.health/portfolio/artifex https://www.nlc.health/portfolio/audaxis-medical https://www.nlc.health/portfolio/axial https://www.nlc.health/portfolio/concord-neonatal https://www.nlc.health/portfolio/crainio https://www.nlc.health/portfolio/exolvo-biosciences https://www.nlc.health/portfolio/garland-surgical https://www.nlc.health/portfolio/genorare https://www.nlc.health/portfolio/haermonics https://www.nlc.health/portfolio/hapticheart-solutions https://www.nlc.health/portfolio/hemeo https://www.nlc.health/portfolio/implant-preservation-devices-ipd https://www.nlc.health/portfolio/intercept-tx https://www.nlc.health/portfolio/kaminari-medical https://www.nlc.health/portfolio/karla-therapeutics https://www.nlc.health/portfolio/lamina https://www.nlc.health/portfolio/lumabs https://www.nlc.health/portfolio/midland-pharmaceutical https://www.nlc.health/portfolio/mindaffect https://www.nlc.health/portfolio/mir-therapeutics https://www.nlc.health/portfolio/mla-diagnostics https://www.nlc.health/portfolio/nc-biomatrix https://www.nlc.health/portfolio/neurodys-therapeutics https://www.nlc.health/portfolio/neurolieve-biosciences https://www.nlc.health/portfolio/nicolab https://www.nlc.health/portfolio/nilocas https://www.nlc.health/portfolio/occlunova https://www.nlc.health/portfolio/pep-health https://www.nlc.health/portfolio/persuasive https://www.nlc.health/portfolio/porous-gmbh https://www.nlc.health/portfolio/profionics https://www.nlc.health/portfolio/provasctec https://www.nlc.health/portfolio/respiosa https://www.nlc.health/portfolio/revadix https://www.nlc.health/portfolio/rheumasense https://www.nlc.health/portfolio/sansepsis https://www.nlc.health/portfolio/scinvivo https://www.nlc.health/portfolio/serda https://www.nlc.health/portfolio/sigilla-medical https://www.nlc.health/portfolio/startric https://www.nlc.health/portfolio/ultratil-medical https://www.nlc.health/portfolio/venous-stent https://www.nlc.health/portfolio/wavefront https://www.nlc.health/portfolio/xtrna-bio https://www.nlc.health/function/fund-management https://www.nlc.health/function/leads https://www.nlc.health/function/management-team https://www.nlc.health/function/supervisory-board https://www.nlc.health/function/venture-partners